Literature DB >> 15670289

Double jeopardy: HIV and cervical cancer in Indian women.

V Sahasrabuddhe1, S Makhija.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15670289      PMCID： PMC2837929          DOI： 10.1111/j.1048-891X.2005.15001.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


× No keyword cloud information.
  29 in total

1.  A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation.

Authors:  A Singer; M Coppleson; K Canfell; V Skladnev; G Mackellar; N Pisal; A Deery
Journal:  Int J Gynecol Cancer       Date:  2003 Nov-Dec       Impact factor: 3.437

Review 2.  Use of visual screening methods for cervical cancer screening.

Authors:  Thomas C Wright; Lynette Denny; Louise Kuhn; Sue Goldie
Journal:  Obstet Gynecol Clin North Am       Date:  2002-12       Impact factor: 2.844

3.  Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  M Frisch; R J Biggar; J J Goedert
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

4.  A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.

Authors:  Qinjing Pan; Jerome L Belinson; Ling Li; Robert G Pretorius; You Lin Qiao; Wen Hua Zhang; Xun Zhang; Ling Ying Wu; Sou De Rong; Yun Tian Sun
Journal:  Acta Cytol       Date:  2003 Jan-Feb       Impact factor: 2.319

5.  Cervical intraepithelial changes & HIV infection in women attending sexually transmitted disease clinics in Pune, India.

Authors:  S Joshi; A Chandorkar; G Krishnan; A Walimbe; R Gangakhedkar; A Risbud; V Jadhav; R Bollinger; S Mehendale
Journal:  Indian J Med Res       Date:  2001-05       Impact factor: 2.375

6.  Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.

Authors:  Stephen E Hawes; Cathy W Critchlow; Mame A Faye Niang; Mame B Diouf; Aissatou Diop; Papa Touré; Abdoul Aziz Kasse; Birama Dembele; Papa Salif Sow; Awa M Coll-Seck; Jane M Kuypers; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2003-07-23       Impact factor: 5.226

7.  Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Authors:  M Branca; A R Garbuglia; A Benedetto; T Cappiello; L Leoncini; G Migliore; A Agarossi; K Syrjänen
Journal:  Int J STD AIDS       Date:  2003-06       Impact factor: 1.359

8.  Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

Authors:  Paula Schuman; Suzanne E Ohmit; Robert S Klein; Ann Duerr; Susan Cu-Uvin; Denise J Jamieson; Jean Anderson; Keerti V Shah
Journal:  J Infect Dis       Date:  2003-06-17       Impact factor: 5.226

9.  Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women.

Authors:  Isabelle Heard; Jean-Michel Tassie; Michel D Kazatchkine; Gérard Orth
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

Review 10.  Toward a reduction of the global burden of cervical cancer.

Authors:  Thomas E Rohan; Robert D Burk; Eduardo L Franco
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661
View more
  2 in total

1.  "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India.

Authors:  Timothy-Paul H Kung; Janna R Gordon; Asha Abdullahi; Apurva Barve; Vipul Chaudhari; Jayendrakumar K Kosambiya; Ambuj Kumar; Sukesha Gamit; Kristen J Wells
Journal:  Cancer Causes Control       Date:  2019-02-26       Impact factor: 2.506

2.  Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providers.

Authors:  Alister C Munthali; Bagrey M Ngwira; Frank Taulo
Journal:  Patient Prefer Adherence       Date:  2015-03-24       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.